Larisa Schwartzman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33100 Cleveland Clinic Blvd, Avon, OH 44011 Phone: 440-695-4000 |
Dr. Adriana Lorena Alvarez, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33100 Cleveland Clinic Blvd, Avon, OH 44011 Phone: 440-695-4320 |
News Archive
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Humana Inc. to accelerate the adoption of electronic health records (EHRs) and the exchange of critical health and billing information among health care providers.
As part of a 40-site national trial, researchers at UT Southwestern Medical Center are studying a new medical device designed to treat patients with chronic congestive heart failure.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
Patients with tumors that contain increased numbers of T lymphocytes generally survive longer than those with tumors without T-cell involvement, suggesting that T cells with potent antitumor function naturally exist in cancer and control tumor progression. With the exception of melanoma, it has been difficult to identify and isolate the tumor-reactive T cells from common cancers, however, the ability to do so could be used to fight a patient's own cancer.
Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious complications for transplant patients.
› Verified 4 days ago